Viking Therapeutics Inc (VKTX)

Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	41.11%187.11	132.60	164.13	164.74	98.56
Research and Development	44.10%166.80	115.75	150.15	153.46	89.95
Operating Income/Loss	41.11%-187.11	-132.60	-164.13	-164.74	-98.56
	43.09%-183.19	-128.02	-158.33	-157.66	-90.79
Attributable To Parent	43.09%-183.19	-128.02	-158.33	-157.66	-90.79
Basic Average Shares	1.54%118.05	116.26	115.57	0.45	112.32
Diluted Average Shares	1.54%118.05	116.26	115.57	0.45	112.32
Basic Earnings Per Share	40.91%-1.55	-1.10	-1.37	-1.39	-0.81
Diluted Earnings Per Share	40.91%-1.55	-1.10	-1.37	-1.39	-0.81